Julian Buchrieser
Overview
Explore the profile of Julian Buchrieser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
2976
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vernuccio R, Martinez Leon A, Poojari C, Buchrieser J, Selverian C, Jaleta Y, et al.
Nat Microbiol
. 2025 Feb;
10(3):734-748.
PMID: 39939832
Mpox is a zoonotic disease endemic to Central and West Africa. Since 2022, two human-adapted monkeypox virus (MPXV) strains have caused large outbreaks outside these regions. Tecovirimat is the most...
2.
Tomasini C, Cuche C, Ay S, Collard M, Cui B, Rashid M, et al.
bioRxiv
. 2024 Dec;
PMID: 39677677
Viruses rely on host cellular machinery for replication. After entering the nucleus, the HIV genome accumulates in nuclear niches where it undergoes reverse transcription and integrates into neighboring chromatin, promoting...
3.
Bolland W, Marechal I, Petiot C, Porrot F, Guivel-Benhassine F, Brelot A, et al.
J Virol
. 2024 Nov;
99(1):e0182324.
PMID: 39570043
Membrane fusion occurs at the early stages of SARS-CoV-2 replication, during entry of the virus, and later during the formation of multinucleated cells called syncytia. Fusion is mediated by the...
4.
Fourati S, Reslan A, Bourret J, Casalegno J, Rahou Y, Chollet L, et al.
Lancet Infect Dis
. 2024 Oct;
25(3):301-311.
PMID: 39419046
Background: Nirsevimab, a long-acting monoclonal antibody, has been approved for the prevention of respiratory syncytial virus (RSV) infection in infants. In France, more than 210 000 single doses were administered...
5.
Vernuccio R, Martinez Leon A, Poojari C, Buchrieser J, Selverian C, Jaleta Y, et al.
Res Sq
. 2024 Oct;
PMID: 39399667
Mpox is a zoonotic disease endemic in central and west Africa. However, since 2022, human-adapted mpox virus (MPXV) strains are causing large outbreaks spreading outside these regions, leading the World...
6.
Fernandez I, Saunders N, Duquerroy S, Bolland W, Arbabian A, Baquero E, et al.
Cell
. 2024 Jul;
187(16):4246-4260.e16.
PMID: 38964326
The human seasonal coronavirus HKU1-CoV, which causes common colds worldwide, relies on the sequential binding to surface glycans and transmembrane serine protease 2 (TMPRSS2) for entry into target cells. TMPRSS2...
7.
Saunders N, Monel B, Cayet N, Archetti L, Moreno H, Jeanne A, et al.
Nat Commun
. 2024 Jun;
15(1):4996.
PMID: 38862527
Assessing the impact of SARS-CoV-2 on organelle dynamics allows a better understanding of the mechanisms of viral replication. We combine label-free holotomographic microscopy with Artificial Intelligence to visualize and quantify...
8.
Brunet J, Choucha Z, Gransagne M, Tabbal H, Ku M, Buchrieser J, et al.
J Virol
. 2024 Apr;
98(5):e0169323.
PMID: 38563763
In the early COVID-19 pandemic with urgent need for countermeasures, we aimed at developing a replicating viral vaccine using the highly efficacious measles vaccine as vector, a promising technology with...
9.
Planas D, Staropoli I, Michel V, Lemoine F, Donati F, Prot M, et al.
Nat Commun
. 2024 Mar;
15(1):2254.
PMID: 38480689
The unceasing circulation of SARS-CoV-2 leads to the continuous emergence of novel viral sublineages. Here, we isolate and characterize XBB.1, XBB.1.5, XBB.1.9.1, XBB.1.16.1, EG.5.1.1, EG.5.1.3, XBF, BA.2.86.1 and JN.1 variants,...
10.
Bolland W, Michel V, Planas D, Hubert M, Staropoli I, Guivel-Benhassine F, et al.
J Virol
. 2023 Dec;
98(1):e0135123.
PMID: 38088562
SARS-CoV-2 variants with undetermined properties have emerged intermittently throughout the COVID-19 pandemic. Some variants possess unique phenotypes and mutations which allow further characterization of viral evolution and Spike functions. Around...